腾盛博药-B在2025 EASL会议上以最新突破海报的形式公布其正在进行的ENSURE 2期研究数据

格隆汇资讯
08 May

格隆汇5月8日丨腾盛博药-B(02137.HK)发布公告,公司在荷兰阿姆斯特丹举行的2025年欧洲肝病研究协会 (EASL)会议上以最新突破海报的形式公布其正在进行的ENSURE 2期研究数据。ENSURE(NCT05970289)是一项多中心、开放性2期研究。队列1-3旨在评估elebsiran,一种研究性小干扰核糖核酸(“siRNA”)在与聚乙二醇干扰素α(“PEG-IFNα”)联合治疗基线...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10